Endovascular Therapy in Patients With Acute Deep Vein Thrombosis

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions
Acute Deep Venous Thrombosis
Interventions
DEVICE

Mechanical / pharmacomechanical thrombectomy plus local catheter directed thrombolysis

"* Catheter directed thrombolysis (CDT): dedicated thrombolytic catheter with side holes is placed across the acute thrombus, and slow, continuous infusion (through the catheter, or both through the catheter and sheath) of a chemical thrombolysis agent is applied - alteplase 1mg/hour plus unfractionated heparine in anticoagulation dosage;~* Mechanical thrombectomy: mechanical aspiration of fresh thrombus;~* Pharmacomechanical thrombectomy (PMT): combination of mechanical disruption of the thrombus, and its aspiration, with simultaneous application of alteplase via dedicated catheter - instilation of acute/subacute thrombus with its subsequent aspiration;"

DEVICE

Local catheter directed thrombolysis alone

\- Catheter directed thrombolysis (CDT): dedicated thrombolytic catheter with side holes is placed across the acute thrombus, and slow, continuous infusion (through the catheter, or both through the catheter and sheath) of a chemical thrombolysis agent is applied - alteplase 1mg/hour plus unfractionated heparine in anticoagulation dosage;

Trial Locations (3)

974 01

Central Slovakia Institute of Cardiovascular Diseases in Banská Bystrica, Banská Bystrica

833 48

National Institute of Cardiovascular Diseases, Slovakia, Bratislava

04011

East Slovakia Institute of Cardiovascular Diseases in Košice, Košice

All Listed Sponsors
collaborator

East Slovakia Institute of Cardiovascular Diseases in Košice, Slovakia

UNKNOWN

collaborator

Central Slovakia Institute of Cardiovascular Diseases in Banská Bystrica, Slovakia

UNKNOWN

lead

National Institute of Cardiovascular Diseases, Slovakia

OTHER

NCT05827120 - Endovascular Therapy in Patients With Acute Deep Vein Thrombosis | Biotech Hunter | Biotech Hunter